Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Cited by (1,018)

Items 301–400 of 1,018

1. Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014
   Yong Liao, Xuelian Lu, Suteng Yang, Yi Luo, Qi Chen, Rongya Yang · 2015 · Open Forum Infectious Diseases
2. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011
   René‐Jean Bensadoun, Lauren L. Patton, Rajesh V. Lalla, Joel Brian Epstein · 2011 · Supportive Care in Cancer
3. What Is the Success of Treatment of Hip and Knee Candidal Periprosthetic Joint Infection?
   Steve Wen‐Neng Ueng, Ching‐Yu Lee, Chih-Chien Hu, Pang‐Hsin Hsieh, Yu‐Han Chang · 2013 · Clinical Orthopaedics and Related Research
4. Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient
   Florence Chapeland‐Leclerc, C. Hennequin, Nicolas Papon, Thierry Noël, Aurélie Girard, Gèrard Socié, Patricia Ribaud, Céline Lacroix · 2009 · Antimicrobial Agents and Chemotherapy
5. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi
   Andrew M. Borman, M. Dean Palmer, Laurence Delhaès, Jacqueline Carrère, Loïc Favennec, Stéphane Ranque, Jean‐Pierre Gangneux, R. Horré, Jean‐Philippe Bouchara · 2010 · Medical Mycology
6. Invasive fungal disease in PICU: epidemiology and risk factors
   Olivier Brissaud, Julie Guichoux, Jérôme Harambat, Olivier Tandonnet, Theoklis E. Zaoutis · 2012 · Annals of Intensive Care
7. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
   David Oxman, Jennifer K. L. Chow, György Frendl, Susan Hadley, S. Hershkovitz, P. Ireland, Laura A. McDermott, K. Tsai, Francisco M. Marty, Dimitrios P. Kontoyiannis et al. · 2010 · Journal of Antimicrobial Chemotherapy
8. Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents
   Hong-Leong Cheah, Vuanghao Lim, Doblin Anak Sandai · 2014 · PLoS ONE
9. Multicenter Study Evaluating the Vitek MS System for Identification of Medically Important Yeasts
   Lars F. Westblade, Rebecca Jennemann, John A. Branda, Maureen Bythrow, Mary Jane Ferraro, Omai B. Garner, Christine C. Ginocchio, Michael A. Lewinski, Ryhana Manji, A. Brian Mochon et al. · 2013 · Journal of Clinical Microbiology
10. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon
    Nahed Ghaddar, Elie Anastasiadis, Rawad Halimeh, Ali Ghaddar, Rita Dhar, Wadha Ahmed Alfouzan, Hoda Yusef, Mira El Chaar · 2020 · BMC Infectious Diseases
11. Use of Antifungal Combination Therapy: Agents, Order, and Timing
    Melissa D. Johnson, John R. Perfect · 2010 · Current Fungal Infection Reports
12. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system
    Maryam Moazeni, Hamidreza Kelidari, Majid Saeedi, Katayoun Morteza‐Semnani, Mojtaba Nabili, Atefeh Abdollahi Gohar, Jafar Âkbari, Ensieh Lotfali, Ali Nokhodchi · 2016 · Colloids and Surfaces B Biointerfaces
13. Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model
    Zhao, Yanan, Prideaux, Brendan, Nagasaki, Yoji, Lee, Min Hee, Chen, Pei-Yu, Blanc, Landry, Ho, Hsinpin, Clancy, Cornelius J., Nguyen, Minh Hong, Dartois, Véronique et al. · 2017 · Antimicrobial Agents and Chemotherapy
14. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
    Leroy, Olivier, Bailly, Sébastien, Gangneux, Jean-Pierre, Mira, Jean-Paul, Devos, Patrick, Dupont, Hervé, Montravers, Philippe, Perrigault, Pierre-François, Constantin, Jean-Michel, Guillemot, Didier et al. · 2016 · Annals of Intensive Care
15. Candida in Solid Organ Transplant Recipients
    Peter G. Pappas, Fernanda P. Silveira · 2009 · American Journal of Transplantation
16. Clinical Features of Candidiasis in Patients With Inherited Interleukin 12 Receptor β1 Deficiency
    Monia Ouederni, Özden Sanal, Aydan İkincioğulları, İlhan Tezcan, Figen Doğu, Ithaisa Sologuren, Sigifredo Pedraza‐Sánchez, Melike Emiroğlu, Gönül Tanır, Chris M. G. Nieuwhof et al. · 2013 · Clinical Infectious Diseases
17. Candidemia in children
    Theoklis E. Zaoutis · 2010 · Current Medical Research and Opinion
18. Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
    Henrique Marconi Sampaio Pinhati, Luíz Augusto Casulari, Ana Carolina Remondi Souza, Ricardo Andreotti Siqueira, Camila Maria Gomes Damasceno, Arnaldo Lopes Colombo · 2016 · BMC Infectious Diseases
19. Interactions between Human Phagocytes andCandida albicansBiofilms Alone and in Combination with Antifungal Agents
    Aspasia Katragkou, Michael J. Kruhlak, Maria Simitsopoulou, Athanasios Chatzimoschou, Άννα Ταπάρκου, Catherine J. Cotten, Fotini Paliogianni, Eudoxia Diza-Mataftsi, Chaido Tsantali, Thomas J. Walsh et al. · 2010 · The Journal of Infectious Diseases
20. Aneuploidy Enables Cross-Adaptation to Unrelated Drugs
    Yang, Feng, Teoh, Flora, Tan, Alrina Shin Min, Cao, Yongbing, Pavelka, Norman, Berman, Judith · 2019 · Molecular Biology and Evolution
21. Current Epidemiology of Candida Infection
    Lockhart, Shawn R. · 2014 · Clinical Microbiology Newsletter
22. Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
    Lewis, James S., Wiederhold, Nathan P., Wickes, Brian L., Patterson, Thomas F., Jorgensen, James H. · 2013 · Antimicrobial Agents and Chemotherapy
23. Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.
    Vazquez, Jose, Reboli, Annette C, Pappas, Peter G, Patterson, Thomas F, Reinhardt, John, Chin-Hong, Peter, Tobin, Ellis, Kett, Daniel H, Biswas, Pinaki, Swanson, Robert · 2014 · BMC Infectious Diseases
24. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
    Matteo Bassetti, Elda Righi, Philippe Montravers, Oliver A. Cornely · 2017 · Journal of Antimicrobial Chemotherapy
25. EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management
    Sibylle C. Mellinghoff, Martin Hoenigl, Philipp A. Koehler, Anil Kumar, Katrien Lagrou, Cornelia Lass‐Flörl, Jacques F. G. M. Meis, Vidya P. Menon, Riina Rautemaa‐Richardson, Oliver A. Cornely · 2018 · Mycoses
26. Treatment of invasive candidiasis in the elderly: a review
    George Dimοpoulos, Aikaterini Flevari, Μαρία Θεοδωρακοπούλου, VELEGRAKI, Armaganidis · 2013 · Clinical Interventions in Aging
27. Urinary Tract Infection
    Lindsay E. Nicolle · 2013 · Critical Care Clinics
28. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
    Daniel H. Kett, Andrew F. Shorr, Annette C. Reboli, Arlene L. Reisman, Pinaki Biswas, Haran T. Schlamm · 2011 · Critical Care
29. Management of invasive fungal infections: a role for polyenes
    Chandrasekar, P. · 2011 · Journal of Antimicrobial Chemotherapy
30. Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry
    Carine Marinach, Arnaud Fekkar, Ralitsa Atanasova, Johanna Gomes, Laura Djamdjian, Jean‐Yves Brossas, I. Meyer, Pierre A. Buffet, Georges Snounou, A. Datry et al. · 2010 · PLoS ONE
31. Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs
    Mariana Castanheira, Leah N. Woosley, Daniel J. Diekema, Ronald N. Jones, Michael A. Pfaller · 2012 · Journal of Clinical Microbiology
32. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology ( AGIHO )
    Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, Maximilian Christopeit, Axel G. Hamprecht, Werner Heinz, Claus Peter Heußel, Marius Horger, Oliver Kurzai, Meinolf Karthaus et al. · 2018 · Mycoses
33. Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014
    The Candidemia Study Group, Francesco Barchiesi, Elena Orsetti, Rosaria Gesuita, Edlira Skrami, Esther Manso · 2015 · Infection
34. Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
    Perlin, David S. · 2014 · Drugs
35. Nationwide Study of Candidemia, Antifungal Use, and Antifungal Drug Resistance in Iceland, 2000 to 2011
    Lena Rós Ásmundsdóttir, Helga Erlendsdóttir, Magnús Gottfreðsson · 2012 · Journal of Clinical Microbiology
36. Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
    Michael A. Pfaller, Shawn A. Messer, Mary R. Motyl, Ronald N. Jones, Mariana Castanheira · 2012 · Journal of Antimicrobial Chemotherapy
37. Infectious Diseases and the Liver
    Rohit Talwani, Bruce L. Gilliam, Charles D. Howell · 2010 · Clinics in Liver Disease
38. Fungal peri-prosthetic joint infection after primary total knee replacement
    B-H. Hwang, J-Y. Yoon, Chang-Hyun Nam, K.A. Jung, S-C. Lee, C-D. Han, S-H. Moon · 2012 · Journal of Bone and Joint Surgery - British Volume
39. CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility
    Krishnan, B Radha, James, Kenneth D, Polowy, Karen, Bryant, B J, Vaidya, Anu, Smith, Steve, Laudeman, Christopher P · 2017 · The Journal of Antibiotics
40. Antifungal therapy in invasive fungal infections
    Sharon C.‐A. Chen, Elliott Geoffrey Playford, Tania Christine Sorrell · 2010 · Current Opinion in Pharmacology
41. Therapeutic management of peritonitis: a comprehensive guide for intensivists
    Philippe Montravers, Stijn I. Blot, G. Dimopoulos, Christian Eckmann, Philippe Eggimann, Xavier Guirao, José Artur Paiva, Gabriele Sganga, Jan J. De Waele · 2016 · Intensive Care Medicine
42. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
    José Garnacho‐Montero, Pedro Olaechea, Francisco Álvarez-Lerma, Luis Álvarez-Rocha, José Blanquer, Beatriz Galván, Alejandro H. Rodríguez, Rafael Zaragoza, José María Aguado, José Mensa et al. · 2013 · PubMed
43. Candida and its dual lifestyle as a commensal and a pathogen
    Mathieu Cauchie, Stefanie Desmet, Katrien Lagrou · 2017 · Research in Microbiology
44. Genital Mycotic Infections in Patients With Diabetes
    Paul Nyirjesy, Jack D. Sobel · 2013 · Postgraduate Medicine
45. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis
    S. Y. Hwang, Su Jong Yu, Jeong‐Hoon Lee, J. S. Kim, J. W. Yoon, Yoon Jun Kim, Jung‐Hwan Yoon, Eui-Chong Kim, H.-S. Lee · 2013 · European Journal of Clinical Microbiology & Infectious Diseases
46. Azole Resistance by Loss of Function of the Sterol Δ 5,6 -Desaturase Gene ( ERG3 ) in Candida albicans Does Not Necessarily Decrease Virulence
    Luís A. Vale-Silva, Alix T. Coste, Françoise Ischer, Josie E. Parker, Steven L. Kelly, Eugénia Pinto, Dominique Sanglard · 2012 · Antimicrobial Agents and Chemotherapy
47. Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis
    Berkow, Elizabeth L., Manigaba, Kayihura, Parker, Josie E., Barker, Katherine S., Kelly, Stephen L., Rogers, P. David · 2015 · Antimicrobial Agents and Chemotherapy
48. Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using an In Vivo Murine Invasive Candidiasis Model
    Alexander J. Lepak, Karen Marchillo, David R. Andes · 2014 · Antimicrobial Agents and Chemotherapy
49. Topical ketoconazole: a systematic review of current dermatological applications and future developments
    Franchesca D. Choi, Margit L. W. Juhász, Natasha Atanaskova Mesinkovska · 2019 · Journal of Dermatological Treatment
50. Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
    Annette C. Reboli, Andrew F. Shorr, Coleman Rotstein, Peter G. Pappas, Daniel H. Kett, Haran T. Schlamm, Arlene L. Reisman, Pinaki Biswas, Thomas J. Walsh · 2011 · BMC Infectious Diseases
51. Advances in Identification of Clinical Yeast Isolates by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
    Blake W. Buchan, Nathan A. Ledeboer · 2013 · Journal of Clinical Microbiology
52. Fungal endocarditis: current challenges
    Pierre Tattevin, Matthieu Revest, Agnès Lefort, C. Michelet, Olivier Lortholary · 2014 · International Journal of Antimicrobial Agents
53. Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea
    Dong‐Gun Lee, Sung‐Han Kim, Soo Young Kim, Chung-Jong Kim, Wan Beom Park, Young Goo Song, Jung‐Hyun Choi · 2011 · The Korean Journal of Internal Medicine
54. Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia
    Heather M. Arnold, Scott T. Micek, Andrew F. Shorr, Marya D. Zilberberg, Andrew J. Labelle, Smita Kothari, Marin H. Kollef · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
55. Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
    Kaur, Harsimran, Chakrabarti, Arunaloke · 2017 · Journal of Fungi
56. Determinants of mortality in non-neutropenic ICU patients with candidaemia.
    Marriott, Deborah JE, Playford, E Geoffrey, Chen, Sharon, Slavin, Monica, Nguyen, Quoc, Ellis, David, Sorrell, Tania C, the Australian Candidaemia Study · 2009 · Critical Care
57. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
    Matteo Bassetti, Filippo Ansaldi, Laura Ambra Nicolini, Emanuele Nadir Malfatto, Maria Pia Molinari, Michele Mussap, Barbara Rebesco, Franco Bobbio Pallavicini, Giancarlo Icardi, Claudio Viscoli · 2009 · Journal of Antimicrobial Chemotherapy
58. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients
    Michelle E. Science, Paula D. Robinson, Tamara MacDonald, Shahrad Rod Rassekh, L. Lee Dupuis, Lillian Sung · 2013 · Pediatric Blood & Cancer
59. Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases
    Francesco Barchiesi, Susanna Mazzocato, Sara Mazzanti, Rosaria Gesuita, Edlira Skrami, Alessandro Fiorentini, Nina Singh · 2014 · Liver Transplantation
60. Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol
    A. Saad, Mariam Fadli, Mohamed Ali Bouaziz, Ahmed Benharref A, Nour-Eddine Mezrioui, Lahcen Hassani · 2010 · Phytomedicine
61. Recent advances in delivery of antifungal agents for therapeutic management of candidiasis
    Bhakti Sawant, Tabassum Asif Khan · 2017 · Biomedicine & Pharmacotherapy
62. Evaluation of “Candida score” in critically ill patients: A prospective, multicenter, observational, cohort study
    Leroy, Guillaume, Lambiotte, Fabien, Thévenin, Didier, Lemaire, Christian, Parmentier, Erika, Devos, Patrick, Leroy, Olivier · 2011 · Annals of Intensive Care
63. Oral Fungal Infections
    David R. Telles, Niraj Karki, Michael W. Marshall · 2017 · Dental Clinics of North America
64. Fungal endophthalmitis
    Jay Kumar Chhablani · 2011 · Expert Review of Anti-infective Therapy
65. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy
    Tyree Heath Kiser, Douglas N. Fish, Christina L. Aquilante, Joseph E. Rower, Michael F. Wempe, Robert MacLaren, Isaac Teitelbaum · 2015 · Critical Care
66. New Fks Hot Spot for Acquired Echinocandin Resistance in Saccharomyces cerevisiae and Its Contribution to Intrinsic Resistance of Scedosporium Species
    Michael E. Johnson, Säntosh K. Katiyar, Thomas D. Edlind · 2011 · Antimicrobial Agents and Chemotherapy
67. Regional data analysis of Candida non‐albicans strains collected in United States medical sites over a 6‐year period, 2006–2011
    Michael A. Pfaller, Ronald N. Jones, Mariana Castanheira · 2014 · Mycoses
68. Fungal Endocarditis: Update on Diagnosis and Management
    Ahmed Khurshid Pasha, Justin Z. Lee, See‐Wei Low, HEM H DESAI, Kwan Seung S Lee, Mayar Al Mohajer · 2016 · The American Journal of Medicine
69. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method
    Ana Espinel‐Ingroff, Maiken Cavling Arendrup, Rafael Cantón, Susana Beatriz Córdoba, Éric Dannaoui, Julio García‐Rodríguez, Gloria María González, Nelesh Premapragasan Govender, Estrella Martín‐Mazuelos, Michaela Lackner et al. · 2016 · Antimicrobial Agents and Chemotherapy
70. Enfermedades Infecciosas y Microbiología Clínica
    Diego Viasus, Andrés Antón, Tomàs Pumarola, Jordi Carratalà · 2016
71. <i>De Novo</i> Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance
    Jiménez-Ortigosa, Cristina, Perez, Winder B., Angulo, David, Borroto-Esoda, Katyna, Perlin, David S. · 2017 · Antimicrobial Agents and Chemotherapy
72. Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies
    Elizabeth J. Polvi, Xinliu Li, Teresa R. O’Meara, Michelle D. Leach, Leah E. Cowen · 2015 · Cellular and Molecular Life Sciences
73. Antimicrobial Properties of Capsaicin: Available Data and Future Research Perspectives
    Aristodemos-Theodoros Periferakis, Argyrios Periferakis, Konstantinos Periferakis, Ana Căruntu, Ioana Anca Bădărău, Ilinca Săvulescu-Fiedler, Cristian Scheau, Constantin Căruntu · 2023 · Nutrients
74. Update on the optimal use of voriconazole for invasive fungal infections
    George R. Thompson, Lat · 2011 · Infection and Drug Resistance
75. Using Galleria mellonella–Candida albicans Infection Model to Evaluate Antifungal Agents
    Dedong Li, Li Deng, Gan-Hai Hu, Lan‐Xue Zhao, Dandan Hu, Yuanying Jiang, Yan Wang · 2013 · Biological and Pharmaceutical Bulletin
76. Best practices for the use of itraconazole as a replacement for ketoconazole in drug–drug interaction studies
    Lichuan Liu, Akintunde Bello, Mark J. Dresser, Donald Heald, Steven F. Komjathy, Edward M. O'Mara, Mark C. Rogge, Selwyn Aubrey Stoch, Sarah M. C. Robertson · 2015 · The Journal of Clinical Pharmacology
77. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans
    Na Guo, Jingbo Liu, Xiuping Wu, Xingming Bi, Rizeng Meng, Xuelin Wang, Hua Xiang, Xuming Deng, Lu Yu · 2009 · Journal of Medical Microbiology
78. Global Identification of Biofilm-Specific Proteolysis in Candida albicans
    Michael B. Winter, Eugenia C. Salcedo, Matthew B. Lohse, Nairi Hartooni, Megha Gulati, Hiram Sánchez, Julie Takagi, Bernhard Hube, David R. Andes, Alexander D. Johnson et al. · 2016 · mBio
79. Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
    Russell Edward Lewis · 2009 · Current Medical Research and Opinion
80. MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis
    Spec, Andrej, Pullman, John, Thompson, George R, Powderly, William G, Tobin, Ellis H, Vazquez, Jose, Wring, Stephen A, Angulo, David, Helou, Silvia, Pappas, Peter G et al. · 2019 · Journal of Antimicrobial Chemotherapy
81. Routine Identification of Medical Fungi by the New Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight System with a New Time-Effective Strategy
    Xavier Iriart, Rose‐Anne Lavergne, Judith Fillaux, Alexis Valentin, Jean‐François Magnaval, Antoine Berry, Sophie Cassaing · 2012 · Journal of Clinical Microbiology
82. Osteoarticular Mycoses
    Maria N. Gamaletsou, Blandine Rammaert, Barry D. Brause, Marimelle A. Bueno, Sanjeet Dadwal, Michael W. Henry, Aspasia Katragkou, Dimitrios P. Kontoyiannis, Matthew William McCarthy, Andy O. Miller et al. · 2022 · Clinical Microbiology Reviews
83. A 6-year antifungal stewardship programme in a teaching hospital
    V. Mondain, F. Lieutier, Lilia Hasseine, M. Gari-Toussaint, Maryline Poirée, Caroline Lions, Céline Pulcini · 2013 · Infection
84. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia
    Maiken Cavling Arendrup, Jacques Billé, Éric Dannaoui, Markus Ruhnke, C P Heussel, Christopher C. Kibbler · 2012 · Bone Marrow Transplantation
85. Drug resistance mechanisms and their regulation in non- albicans Candida species
    Anna Kołaczkowska, Marcin Kołaczkowski · 2016 · Journal of Antimicrobial Chemotherapy
86. Essentials for Selecting Antimicrobial Therapy for Intra-Abdominal Infections
    Stijn I. Blot, Jan J. De Waele, Dirk Vogelaers · 2012 · Drugs
87. Antimicrobial Photodynamic Inactivation Inhibits Candida albicans Virulence Factors and Reduces In Vivo Pathogenicity
    Ilka Tiemy Kato, Renato Araújo Prates, Caetano P. Sabino, Beth Burgwyn Fuchs, George P. Tegos, Eleftherios E Mylonakis, Michael Richard Hamblin, Martha Simões Ribeiro · 2012 · Antimicrobial Agents and Chemotherapy
88. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: A potential benefit from infectious disease consultation
    Farmakiotis, Dimitrios, Kyvernitakis, A., Tarrand, J.J., Kontoyiannis, D.P. · 2015 · Clinical Microbiology and Infection
89. Infectious Complications After Liver Transplantation.
    Maria Del Pilar Hernandez, Paul Martin, Jacques Simkins · 2015 · PubMed Central
90. Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans
    Irshad Ahamad, Fareha Bano, Razique Anwer, Pooja Srivastava, Raj Kumar, Tasneem Fatma · 2022 · Frontiers in Microbiology
91. Dual Action of Curcumin as an Anti- and Pro-Oxidant from a Biophysical Perspective
    Agnieszka Wolnicka-Głubisz, Anna Wiśniewska-Becker · 2023 · Antioxidants
92. Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients
    Gregory A. Eschenauer, Eun Jeong Kwak, Abhinav Humar, Brian A. Potoski, Lloyd G. Clarke, Ryan K. Shields, R. Abdel‐Massih, Fernanda P. Silveira, P. Verhidis, Cornelius Joseph Clancy et al. · 2014 · American Journal of Transplantation
93. Neonatal candidiasis: Diagnosis, prevention, and treatment
    Rachel G. Greenberg, Daniel K. Benjamin · 2014 · Journal of Infection
94. Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India
    Partha Bhattacharjee · 2016 · Current Medical Mycology
95. Notable Increasing Trend in Azole Non-susceptible Candida tropicalis Causing Invasive Candidiasis in China (August 2009 to July 2014): Molecular Epidemiology and Clinical Azole Consumption
    Fan, Xin, Xiao, Meng, Liao, Kang, Kudinha, Timothy, Wang, He, Zhang, Li, Hou, Xin, Kong, Fanrong, Xu, Ying-Chun · 2017 · Frontiers in Microbiology
96. Antifungal stewardship in invasive Candida infections
    Markus Ruhnke · 2014 · Clinical Microbiology and Infection
97. In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
    Michael A. Pfaller, Shawn A. Messer, Paul R. Rhomberg, Ronald N. Jones, Mariana Castanheira · 2013 · Journal of Clinical Microbiology
98. The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy
    Payal Patel, Joshua E. Erlandsen, William R. Kirkpatrick, Deborah K. Berg, Steven D. Westbrook, Christopher Louden, John E. Cornell, George R. Thompson, Ana C. Vallor, Brian L. Wickes et al. · 2012 · AIDS Research and Treatment
99. Exudative retinal detachment
    Radgonde Amer, Hilal Nalcı, Fatime Nilüfer Yalçındağ · 2017 · Survey of Ophthalmology
100. Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
     Satora, Małgorzata, Grunwald, Arkadiusz, Zaremba, Bartłomiej, Frankowska, Karolina, Żak, Klaudia, Tarkowski, Rafał, Kułak, Krzysztof · 2023 · Journal of Clinical Medicine